↓ Skip to main content

Mandatory disclosure of all pharmaceutical and medical device companies’ payments to healthcare providers: learning from the USA

Overview of attention for article published in Drug & Therapeutics Bulletin, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 885)
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
42 X users
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mandatory disclosure of all pharmaceutical and medical device companies’ payments to healthcare providers: learning from the USA
Published in
Drug & Therapeutics Bulletin, December 2021
DOI 10.1136/dtb.2021.000061
Pubmed ID
Authors

Sidney Wolfe

X Demographics

X Demographics

The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 25%
Unknown 3 75%
Readers by discipline Count As %
Chemical Engineering 1 25%
Nursing and Health Professions 1 25%
Unknown 2 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2024.
All research outputs
#1,755,130
of 26,388,114 outputs
Outputs from Drug & Therapeutics Bulletin
#34
of 885 outputs
Outputs of similar age
#42,144
of 530,512 outputs
Outputs of similar age from Drug & Therapeutics Bulletin
#2
of 11 outputs
Altmetric has tracked 26,388,114 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 885 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,512 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.